Antibodies and fv fragment recognizing antigen ior c2
CA 2359577 A1 · Owner: Perez Rodriguez, Rolando · Inventors: Perez Rodriguez, Rolando; Bell Garcia, Hanssel; Gavilondo Cowley, Jorge Victor
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the obtention of novel recombinant antibodies of novel recombinant antibodies from murine antibody ior C5 produced by the hybridome deposited under number ECCC 97061101 in accordance with the Budapest Treaty. Said recombinant antibodies were obtained using recombinant DNA technology and are characterized in that they recognize antigen ior C2. The recombinant antibodies are specifically chimeric antibody humanized antibody , and the single-chain Fv fragment. The chimeric antibody contains variable domains of murine immunoglobuline and the constant regions of human immunoglobuline. The humanized antibody contains the constant regions of human immunoglobuline …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 16, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 16, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 16, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.